Ascendis Pharma A/S Noncurrent Financial Liabilities
Ascendis Pharma A/S (ASND) had Noncurrent Financial Liabilities of EUR 385.25 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:NoncurrentFinancialLiabilities · last filed 2026-02-11
- 2025-12-31: Noncurrent Financial Liabilities 385.25M EUR.
- 2025-09-30: Noncurrent Financial Liabilities 331.37M EUR.
- 2025-06-30: Noncurrent Financial Liabilities 330.19M EUR.
- 2025-03-31: Noncurrent Financial Liabilities 357.31M EUR.
| Period end | Noncurrent Financial Liabilities | Noncurrent Financial Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 385.25M EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 331.37M EUR 6-K · filed 2025-11-12 | |
| 2025-06-30 | 330.19M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 357.31M EUR 6-K · filed 2025-05-01 | |
| 2024-12-31 | 365.08M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 338.93M EUR 6-K · filed 2024-11-14 | |
| 2024-06-30 | 219.05M EUR 6-K · filed 2024-09-03 | |
| 2024-03-31 | 229.63M EUR 6-K · filed 2024-05-02 | |
| 2023-12-31 | 223.00M EUR 20-F · filed 2025-02-12 | 762.16M EUR 20-F · filed 2024-02-07 |
| 2023-03-31 | 596.76M EUR 6-K · filed 2023-04-27 | |
| 2022-12-31 | 640.91M EUR 20-F · filed 2024-02-07 | |
| 2022-09-30 | 665.88M EUR 6-K · filed 2022-11-02 | |
| 2022-06-30 | 600.16M EUR 6-K · filed 2022-08-10 | |
| 2022-03-31 | 606.12M EUR 6-K · filed 2022-05-11 | |
| 2021-12-31 | 97.97M EUR 20-F · filed 2023-02-16 |